How does Genentech like it under Roche’s wing?

Three years after the Roche ($RHHBY) buyout, how is Genentech faring as a unit of the Swiss company? It's in the midst of a "top-to-bottom redesign" in a "meticulously thought-out" process, Xconomy re…
Read the full story: News